Maintenance of functional CD57+cytolytic CD4+T cells in HIV plus elite controllers
File(s)
Author(s)
Type
Journal Article
Abstract
Cytolytic CD4+ T cells play a prominent role in chronic viral infection. CD4+ CTLs clones specific for HIV-1 Nef and Gag are capable of killing HIV-1 infected CD4+ T cells and macrophages. Additionally, HIV-specific cytolytic CD4+ T cell responses in acute HIV infection are predictive of disease progression. CD57 expression on CD4s identifies cytolytic cells. These cells were dramatically increased in chronic HIV infection. CD57 expression correlated with cytolytic granules, granzyme B and perforin expression. They express lower CCR5 compared to CD57– cells, have less HIV total DNA, and were a minor component of the HIV reservoir. A small percentage of CD57+ CD4+ CTLs from EC were HIV-specific, could upregulate IFNγ with Gag peptide stimulation, express cytolytic granule markers and maintain TbethighEomes+ transcription factor phenotype. This was not observed in viraemic controllers. The maintenance of HIV-specific CD4 cytolytic function in Elite controllers together with CD8 CTLs may be important for the control of HIV viraemia and of potential relevance to cure strategies.
Date Issued
2019-08-08
Date Acceptance
2019-07-22
Citation
Frontiers in Immunology, 2019, 10, pp.1-17
ISSN
1664-3224
Publisher
Frontiers Media
Start Page
1
End Page
17
Journal / Book Title
Frontiers in Immunology
Volume
10
Copyright Statement
© 2019 Phetsouphanh, Aldridge, Marchi, Munier, Meyerowitz, Murray, Van Vuuren, Goedhals, Fidler, Kelleher, Klenerman and Frater. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Sponsor
British HIV Association (BHIVA)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000479222800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
N/A
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
T cells
HIV
viral immunology
CD4 T cells
cytotoxic T cells
CD4(+) T-CELLS
TRANSCRIPTION FACTOR
IN-VIVO
BET
ANTIGEN
RUNX3
EOMES
Publication Status
Published
Article Number
ARTN 1844
Date Publish Online
2019-08-08